Rosano GM - Search Results

1

Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.

Vitale C, Gebara O, Mercuro G, Wajngarten M, Silvestri A, Rossini P, Ramires JA, Fini M, Rosano GM. Vitale C, et al. Among authors: rosano gm. Maturitas. 2005 Apr 11;50(4):239-46. doi: 10.1016/j.maturitas.2003.09.032. Maturitas. 2005. PMID: 15780522 Clinical Trial.

2

Effect of acute administration of estradiol 17 beta on aortic blood flow in menopausal women.

Leonardo F, Medeirus C, Rosano GM, Pereira WI, Sheiban I, Gebara O, Bellotti G, Pileggi F, Chierchia SL. Leonardo F, et al. Among authors: rosano gm. Am J Cardiol. 1997 Sep 15;80(6):791-3. doi: 10.1016/s0002-9149(97)00520-1. Am J Cardiol. 1997. PMID: 9315594 Clinical Trial.

3

Controversial aspects of hormone replacement therapy upon cardiovascular mortality and morbidity of women in menopause.

Rosano GM, Mercuro G. Rosano GM, et al. G Ital Cardiol. 1999 Sep;29(9):999-1003. G Ital Cardiol. 1999. PMID: 10514956 No abstract available.

4

Cardioprotective effects of ovarian hormones and the HERS in perspective.

Rosano GM, Graziottin A, Fini M. Rosano GM, et al. Maturitas. 2000 Apr 1;34 Suppl 2:S3-10. doi: 10.1016/s0378-5122(00)00106-7. Maturitas. 2000. PMID: 10915917 Review.

5

The relative effects of progesterone and progestins in hormone replacement therapy.

Rosano GM, Sarais C, Zoncu S, Mercuro G. Rosano GM, et al. Hum Reprod. 2000 Jun;15 Suppl 1:60-73. doi: 10.1093/humrep/15.suppl_1.60. Hum Reprod. 2000. PMID: 10928419 Review.

6

Hormone replacement therapy: where we stand in Europe.

Rosano GM, Simon T, Mercuro G, Sans S, Schenck-Gustaffson K, Stevenson JC, Swahn E, Jaillon P. Rosano GM, et al. Eur Heart J. 2001 Mar;22(6):439-41. doi: 10.1053/euhj.2000.2298. Eur Heart J. 2001. PMID: 11237534 No abstract available.

7

Hormone replacement therapy and cardiovascular risk: consistency of results and unreliable data.

Rosano GM, Fini M. Rosano GM, et al. Maturitas. 2001 May 30;38(3):225-6. doi: 10.1016/s0378-5122(01)00178-5. Maturitas. 2001. PMID: 11358637 No abstract available.

8

Anti-ischemic effect of chronic oestrogen replacement therapy alone or in combination with medroxyprogesterone acetate in different replacement schemes.

Cerquetani E, Leonardo F, Pagnotta P, Galetta P, Onorati D, Fini M, Rosano GM. Cerquetani E, et al. Among authors: rosano gm. Maturitas. 2001 Sep 28;39(3):245-51. doi: 10.1016/s0378-5122(01)00225-0. Maturitas. 2001. PMID: 11574184 Clinical Trial.

9

Hormone replacement therapy in women with angina with normal coronary arteriograms. Pathogenetic or symptomatic therapy?

Rosano GM, Fini M, Mercuro G. Rosano GM, et al. Eur Heart J. 2001 Nov;22(22):2051-4. doi: 10.1053/euhj.2001.2771. Eur Heart J. 2001. PMID: 11686662 No abstract available.

10

Comparative cardiovascular effects of different progestins in menopause.

Rosano GM, Fini M. Rosano GM, et al. Int J Fertil Womens Med. 2001 Sep-Oct;46(5):248-56. Int J Fertil Womens Med. 2001. PMID: 11720197 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

650 results

Search Page

Filters